Discovery Life Sciences, LLC

Huntsville, AL Doing business as Discovery Life Sciences

UEI
GDJDUFGMSC14
CAGE
665G5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Other
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
800 Hudson Wy NW #1700, Huntsville, AL 35806, USA
Website
dls.com
Founded
2018
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Discovery Life Sciences, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Services, storage, and shipping to obtain HLA-B27+ healthy control biospecimens national institute of arthritis and… Contract · 75N92024P00333 National Heart Lung and Blood Institute $28,690
Primary cryopreserved human hepatocytes and media Contract · 75F40124P00280 Food and Drug Administration $91,630
Long read sequencing Contract · 12805B23P0431 Plains Area $46,320
Discovery life sciences, LLC:1368299 [23-039067] proteomics project management and set-up fee Contract · 75N91023P00750 National Cancer Institute $25,000
Human primary hepatocytes, recovery, plating, and induction media Contract · 75F40123P00249 Food and Drug Administration $47,945

About Discovery Life Sciences, LLC

Discovery Life Sciences, LLC, doing business as Discovery Life Sciences, is a small disadvantaged, for-profit limited liability company registered in SAM.gov since 2010, located in Huntsville, Alabama. The company specializes in providing advanced biomedical research services, including biospecimen procurement, genomic sequencing, proteomics analysis, and multi-omics analytical services to federal agencies. With a demonstrated track record of supporting various federal research initiatives, Discovery Life Sciences offers comprehensive scientific solutions across multiple research domains.

The company has been awarded numerous federal contract purchase orders across multiple agencies, primarily in the biomedical and research sectors. Significant contract awards include work with the National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Cancer Institute, Agricultural Research Service, and National Oceanic and Atmospheric Administration. These contracts encompass diverse services such as providing human hepatocytes, performing long-read sequencing on plant samples, conducting proteomics project management, delivering human peripheral blood mononuclear cells, and executing specialized research support services. Many of these contracts were set aside for small businesses, with contract values ranging from approximately $20,000 to $107,439, demonstrating the company's capability to support varied federal research requirements through firm fixed-price purchase orders.

Regarding grant activities, Discovery Life Sciences has participated in at least one known federal grant sub-award, specifically a sub-award from the University of Alabama at Birmingham focused on characterizing the Lupus Nephritis microRNAome. This sub-award, dated August 8, 2023, indicates the company's involvement in advanced medical research at the molecular level, particularly in understanding complex disease mechanisms. While the provided documentation shows limited grant activity, the sub-award suggests the company's potential capability and interest in contributing to cutting-edge medical research through collaborative grant partnerships with academic institutions.

SBA capabilities narrative

Discovery Life Sciences, Inc. is a dedicated, innovative clinical research products and services Company that delivers ethically obtained Clinical Specimens, Patient Samples, Human Biofluids, annotated data and a wide range of clinical research services in support of novel Biomarker assays, detection technologies and instrument platforms in analytical and clinical development. Our primary goal, through Discovery Partners; our Worldwide network of community engaged Principal Investigators and Magellan; our web based, open access Biobank is to build strong, results-oriented research relationships between our clients in the Life Sciences industry and research motivated Hospitals, Medical Centers, and Physicians in the Community while maintaining the highest possible level of commitment to protecting the rights of human research subjects and the integrity of the delivered products.

Quick answers

What is Discovery Life Sciences, LLC's UEI?

Discovery Life Sciences, LLC's Unique Entity ID (UEI) in SAM.gov is GDJDUFGMSC14.

What is Discovery Life Sciences, LLC's CAGE code?

Discovery Life Sciences, LLC's CAGE code is 665G5.

What is Discovery Life Sciences, LLC's primary NAICS code?

Discovery Life Sciences, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Discovery Life Sciences, LLC located?

Discovery Life Sciences, LLC's physical address in SAM.gov is 800 Hudson Wy NW #1700, Huntsville, AL 35806, USA.

Is Discovery Life Sciences, LLC registered in SAM.gov?

Yes. Discovery Life Sciences, LLC's SAM.gov registration is active through October 31, 2026.

What is Discovery Life Sciences, LLC's most recent federal award?

Discovery Life Sciences, LLC's most recent federal contract award is Services, storage, and shipping to obtain HLA-B27+ healthy control biospecimens national institute of arthritis and… (75N92024P00333), from National Heart Lung and Blood Institute, on September 13, 2024.

On GovTribe

See Discovery Life Sciences, LLC's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors